Getting Started with BENLYSTA
Ask your doctor if you might be a candidate for treatment with BENLYSTA
- It is not known if BENLYSTA is safe and effective in people with severe active lupus nephritis or severe active central nervous system lupus. BENLYSTA has not been studied in combination with other biologics or intravenous cyclophosphamide. Use of BENLYSTA is not recommended in these situations.
- In 2 of 3 studies, fewer blacks/African Americans who received BENLYSTA responded to treatment compared to blacks/African Americans who did not receive BENLYSTA. Therefore, caution should be used when considering treatment with BENLYSTA in blacks/African Americans. It is important to discuss with your healthcare professional whether BENLYSTA is right for you. A clinical trial is ongoing to study BENLYSTA specifically in blacks/African Americans with lupus.
This is not a full list of the things your healthcare professional will need to consider before prescribing BENLYSTA. For more information, refer to the Medication Guide, and talk to your doctor.
Pregnancy and Breastfeeding
Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. Tell your healthcare provider right away if you become pregnant or you think you may be pregnant while receiving treatment with BENLYSTA.
Tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into the breast milk. You and your healthcare provider should discuss whether or not you should receive BENLYSTA and breastfeed.
Women of childbearing age should use an effective method of birth control while receiving BENLYSTA and for at least 4 months after the final dose of BENLYSTA.
If you become pregnant while receiving BENLYSTA, talk to your healthcare provider about enrolling in the Pregnancy Registry for BENLYSTA. You can enroll in this registry by calling 1-877-681-6296. The purpose of this registry is to monitor the health of you and your baby.
Before taking BENLYSTA
Your healthcare professional is your partner in treating lupus and managing your symptoms. He or she can help you best if you share information regarding your overall health.
Tell your healthcare professional if:
- You think you have an infection or have infections that keep coming back. You should not receive BENLYSTA if you have an infection unless your healthcare provider tells you to.
- You have or have had mental health problems such as depression or thoughts of suicide.
- You have recently received a vaccination, or think you may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
- You are allergic to other medicines.
- You are receiving other biologic medicines, monoclonal antibodies, or IV infusions of cyclophosphamide (Cytoxan). The use of BENLYSTA with these medications is not recommended.
- You have or have had any type of cancer.
- You have any other medical conditions.
Remember to tell your healthcare professional about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.
Morgan, Michelle and Susan describe the infusion process and provide helpful tips for passing the time.
Michelle, Susan and Morgan talk about the help they got from BENLYSTA® Gateway, and offer words of advice for other people living with lupus.
GSK sponsors ambassadors for BENLYSTA and pays them for their time and expense in sharing their experiences.
Individual results may vary.